AndreaBozzo/ceres-open-data-index huggingface dataset:
Publications Using SAMHSA DataNational Mental Health Services Survey (N-MHSS): 2018, Data On Mental Health Treatment Facilities

This report presents findings from the 2018 National Mental Health Services Survey (N-MHSS), an annual census of all known facilities in the United States, both public and private, that provide mental health treatment services to people with mental illness. Planned and directed by the Center for Behavioral Health Statistics and Quality (CBHSQ) of the Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services, the N-MHSS is designed to collect data on the location, characteristics, and utilization of organized mental health treatment services for facilities within the scope of the survey throughout the 50 states, the District of Columbia, Puerto Rico, and other jurisdictions.
Compound 527123: 1-Pentanamine, 1-methyl, N-ethyl

Chemical compound data from PubChem database. IUPAC Name: N-ethylhexan-2-amine. Molecular Formula: C8H19N. Molecular Weight: 129.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525490: 1,1-Dimethylpropyl propargyl sulfide

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-2-prop-2-ynylsulfanylbutane. Molecular Formula: C8H14S. Molecular Weight: 142.26. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526208: 2-Methyl-3-[(5-methyl-2,3-dihydrofuran-4-yl)disulfanyl]furan

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-3-[(5-methyl-2,3-dihydrofuran-4-yl)disulfanyl]furan. Molecular Formula: C10H12O2S2. Molecular Weight: 228.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526400: 2-Bromo, 1,3,4,6,7-pentachloro-dibenzo-dioxin

Chemical compound data from PubChem database. IUPAC Name: 2-bromo-1,3,4,6,7-pentachlorodibenzo-p-dioxin. Molecular Formula: C12H2BrCl5O2. Molecular Weight: 435.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527327: Methyl 2-[4-methoxy-3-(trifluoromethyl)anilino]pyridine-3-carboxylate

Chemical compound data from PubChem database. IUPAC Name: methyl 2-[4-methoxy-3-(trifluoromethyl)anilino]pyridine-3-carboxylate. Molecular Formula: C15H13F3N2O3. Molecular Weight: 326.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530190: Imidazole-4,5-dicarboxylic acid, TMS

Chemical compound data from PubChem database. IUPAC Name: bis(trimethylsilyl) 1-trimethylsilylimidazole-4,5-dicarboxylate. Molecular Formula: C14H28N2O4Si3. Molecular Weight: 372.64. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Early Learning Mentor Coach Study (ELMC) 2011-2014

The ELMC Study collected data to describe the objectives, activities, approaches, strategies, and other aspects of the Early Learning Mentor Coach (ELMC) initiative from the perspectives of Head Start grantees, coaches, and staff. In October 2010, the funds to support the ELMC initiative were distributed to 130 Head Start grantees in 42 states and the District of Columbia for a seventeen month period. Grantees used the funds to hire coaches to provide on-the-job guidance, training, mentoring and technical assistance to Head Start staff. The grant recipients reflected the range of Head Start programs. Data was collected using a mixed-methods design (qualitative and quantitative) and the following data collection instruments: a grantee census survey; a coach census survey; coach telephone interviews; and staff telephone interviews with staff who received coaching. 

<b>Units of Response: </b>Head Start Grantees, Head Start Coaches, Head Start Staff

<b>Type of Data: </b>Survey

<b>Tribal Data: </b>No

<b>Periodicity: </b>One-time

<b>Demographic Indicators: </b>Ethnicity;Race

<b>SORN: </b>https://www.federalregister.gov/documents/2022/09/19/2022-20139/privacy-act-of-1974-system-of-records

<b>Data Use Agreement: </b>https://www.icpsr.umich.edu/rpxlogin

<b>Data Use Agreement Location: </b>https://www.childandfamilydataarchive.org/cfda/archives/cfda/studies/36852/datadocumentation

<b>Granularity: </b>Grant;Grantee;Individual

<b>Spatial: </b>United States

<b>Geocoding: </b>State
Colorado (CO)

This report presents estimates for measures of substance use and mental health based on the combined 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Colorado for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Oklahoma (OK)

This report presents estimates for measures of substance use and mental health based on the combined 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Oklahoma for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Clinical evaluation of the Life Support for Trauma and Transport (LSTAT) platform

Introduction
          The Life Support for Trauma and Transport (LSTAT™) is a self-contained, stretcher-based miniature intensive care unit designed by the United States Army to provide care for critically injured patients during transport and in remote settings where resources are limited. The LSTAT contains conventional medical equipment that has been integrated into one platform and reduced in size to fit within the dimensional envelope of a North Atlantic Treaty Organization (NATO) stretcher. This study evaluated the clinical utility of the LSTAT in simulated and real clinical environments. Our hypothesis was that the LSTAT would be equivalent to conventional equipment in detecting and treating life-threatening problems.
        
        
          Methods
          Thirty-one anesthesiologists and recovery room nurses compared the LSTAT with conventional monitors while managing four simulated critical events. The time required to reach a diagnosis and treatment was recorded for each simulation. Subsequently, 10 consenting adult patients were placed on the LSTAT after surgery for postoperative care in the recovery room. Questionnaires about aspects of LSTAT functionality were completed by nine nurses who cared for the patients placed on the LSTAT.
        
        
          Results
          In all of the simulations, there was no clinically significant difference in the time to diagnosis or treatment between the LSTAT and conventional equipment. All clinicians reported that they were able to manage the simulated patients properly with the LSTAT. Nursing staff reported that the LSTAT provided adequate equipment to care for the patients monitored during recovery from surgery and were able to detect critical changes in vital signs in a timely manner.
        
        
          Discussion
          Preliminary evaluation of the LSTAT in simulated and postoperative environments demonstrated that the LSTAT provided appropriate equipment to detect and manage critical events in patient care. Further work in assessing LSTAT functionality in a higher-acuity environment is warranted.
Compound 529370: Ser isoBOC TBDMS #1

Chemical compound data from PubChem database. IUPAC Name: [tert-butyl(dimethyl)silyl] 3-hydroxy-2-(2-methylpropoxycarbonylamino)propanoate. Molecular Formula: C14H29NO5Si. Molecular Weight: 319.47. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Public Health Statistics - Diabetes hospitalizations in Chicago, 2000-2011 - Historical

Note: This dataset is historical only and there are not corresponding datasets for more recent time periods. For that more-recent information, please visit the Chicago Health Atlas at https://chicagohealthatlas.org.

This dataset contains the annual number of hospital discharges, crude hospitalization rates with corresponding 95% confidence intervals, and age-adjusted hospitalization rates with corresponding 95% confidence intervals, for the years 2000 – 2011, by Chicago U.S. Postal Service ZIP code or ZIP code aggregate.   See the full description at http://bit.ly/Os5wnn.
Compound 527743: 2,2,2-Trichloroethyl hexadecanoate

Chemical compound data from PubChem database. IUPAC Name: 2,2,2-trichloroethyl hexadecanoate. Molecular Formula: C18H33Cl3O2. Molecular Weight: 387.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528003: 2-Chloroethyl 3,5-dinitrobenzoate

Chemical compound data from PubChem database. IUPAC Name: 2-chloroethyl 3,5-dinitrobenzoate. Molecular Formula: C9H7ClN2O6. Molecular Weight: 274.61. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526314: 2,3,4,8,9-Pentabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,2,6,7,8-pentabromodibenzofuran. Molecular Formula: C12H3Br5O. Molecular Weight: 562.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525518: 2-(4-Cyclohexylmethoxy-phenyl)-propionic acid, methyl ester

Chemical compound data from PubChem database. IUPAC Name: methyl 2-(4-phenylmethoxyphenyl)propanoate. Molecular Formula: C17H18O3. Molecular Weight: 270.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
CCWIS Technical Bulletin #7

This technical bulletin provides title IV-E agencies that develop a comprehensive child welfare information system (CCWIS) with information about technical assistance, self-assessment tools, and monitoring reviews. The bulletin also includes appendices that present voluntary self-assessment tools that can be downloaded individually or together as a zip file.

Technical Bulletin #7: CCWIS Technical Assistance, Self-Assessment Tools, and Monitoring Reviews  (PDF)

Appendices (ZIP)
			
 (ZIP)

Appendix A — Adoption (DOCX)

Appendix B — Case Management (DOCX)

Appendix C — Foster Care and Service Provider Management (DOCX)

Appendix D — Intake (DOCX)

Appendix E — Investigation (DOCX)

Appendix F — Administration (DOCX)

Appendix G — Data Quality (DOCX)

Appendix H — Design Requirements (DOCX)

Appendix I — Design Scoring Sheet (XLSX)

Appendix J — Reporting (DOCX)

Appendix K — Security (DOCX)

Appendix L — User Experience (DOCX)

Appendix M — Title IV-E Foster Care Maintenance Payment Eligibility (DOCX)

Appendix N — CWCA (DOCX)

Appendix O — Financial (DOCX)

Appendix P — Data Exchanges (DOCX)

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E400245-T1: [Translated] COSMETIC, PREFERABLY SILICONE-FREE SKINCARE PRODUCT CONTAINING PPG-3 BENZYL ETHER MYRISTATE

Cosmetic skin care agent (I) based on fatty acid esters comprises polypropylene glycol (PPG)-3 benzyl ether myristate; an ester derived from n-octanoic acid and n-decanoic acid and 2-ethyl-hydroxymethyl-1,3-propanediol; an ester derived from lactic acid and n-dodecylalcohol; diester derived from 2,2-dimethylpropylglycol and a mixture of n-octanoic acid and n-decanoic acid; an ester derived from a mixture of stearic acid and 2,2-bis(hydroxymethyl)-1,3-propanediol; a quaternary amine; and a remainder of cosmetic auxiliary materials and/or carrier materials. Cosmetic skin care agent (I), on the basis of fatty acid ester, comprises (in wt.%): polypropylene glycol (PPG)-3 benzyl ether myristate (4.9-5.6); an ester derived from n-octanoic acid and n-decanoic acid and 2-ethyl-hydroxymethyl-1,3-propanediol (3.8-4.5); an ester derived from lactic acid and n-dodecylalcohol (2.5-3.5); diester derived from 2,2-dimethylpropylglycol and a mixture of n-octanoic acid and n-decanoic acid (2.5-3.5); an ester derived from a mixture of stearic acid and 2,2-bis(hydroxymethyl)-1,3-propanediol (1-2); a quaternary amine, preferably of rapeseed oil, which contains 22C fatty acid (1-2); and a remainder (up to 100) of cosmetic auxiliary materials and/or carrier materials.
Table 22. Needing But Not Receiving Treatment for Alcohol Use in the Past Year, by Age Group and State: Percentages, Annual Averages Based on 2013 and 2014 NSDUHs

Table 22. Needing But Not Receiving Treatment for Alcohol Use in the Past Year, by Age Group and State: Percentages, Annual Averages Based on 2013 and 2014 NSDUHs
NNDSS - TABLE 1L. Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection to Giardiasis

NNDSS - TABLE 1L. Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection to Giardiasis - 2021. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notice: Due to data processing issues at CDC, data for the following jurisdictions may be incomplete for week 7: Alaska, Arizona, California, Connecticut, Delaware, Florida, Hawaii, Louisiana, Maryland, Michigan, Missouri, North Dakota, New Hampshire, New York City, Oregon, Pennsylvania, and Rhode Island.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
 Max: Maximum — Maximum case count during the previous 52 weeks.
  * Case counts for reporting years 2020 and 2021 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Deaths and Death Rates by Age and Resident County, New York State: Beginning 2018

This dataset contains the number of New York State deaths and death rates by age group and resident county. The data presented here may differ from the Vital Statistics tables on the Department public website due to data updates. For more information, visit  https://www.health.ny.gov/statistics/vital_statistics/vs_reports_tables_list.htm,  where information from this dataset is presented in tabular form in Tables 35 and 36.
Compound 529316: 2,4-Hexadiene, 1-ethoxy-

Chemical compound data from PubChem database. IUPAC Name: 1-ethoxyhexa-2,4-diene. Molecular Formula: C8H14O. Molecular Weight: 126.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400266-T1: [Translated] N-ACYLAMINOACETONITRIL DERIVATIVES AND THEIR USE FOR CONTROLLING PARASITES

Chemical patent from PubChem database. Patent Number: AT-E400266-T1. Title: Chemical Synthesis Method. Filing Date: 1995-07-26. Inventors: Garcia, Maria, Miller, Thomas. Abstract: A novel method for chemical synthesis is provided, utilizing specific catalysts and reaction conditions to achieve selective transformations with high... IPC Classifications: B01J, C07C, C07D. This patent covers 44 claims related to 9 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
Compound 529823: [17-(5,6-dimethylhept-3-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

Chemical compound data from PubChem database. IUPAC Name: [17-(5,6-dimethylhept-3-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate. Molecular Formula: C30H48O2. Molecular Weight: 440.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
1 in 5 Parents Think What They Say Has Little Influence on Their Child\'s Substance Use (2004 to 2011 NSDUH)

This report uses 2004 to 2011 National Survey on Drug Use and Health (NSDUH) to assess whether parents of adolescents aged 12 to 17 thought what they said influenced whether their child used drugs and whether they talked to their child about the dangers of substance use.
Child Care Licensing Study, 2011

The purpose of the 2011 Child Care Licensing Study is to report two aspects of child care licensing from 2011 for all 50 states and the District of Columbia (not including Idaho): (1) state child care licensing programs and policies and (2) child care center and family child care home licensing regulations. The study focuses on the processes and policies in each state related to staffing for the licensing program, monitoring facilities, and enforcement of licensing regulations. 

To collect information on states' licensing policies, including staffing, monitoring, and enforcement of licensing regulations, the National Association for Regulatory Administration (NARA) disseminated the 2011 NARA Child Care Licensing Program Survey to all state child care licensing agencies in May 2012. Responses were received from all states. The survey focused on the processes and policies in each state related to staffing for the licensing program, monitoring facilities, and enforcement of licensing regulations. 

<b>Units of Response: </b>State 

<b>Type of Data: </b>Survey 

<b>Tribal Data: </b>No 

<b>Periodicity: </b>One-time

<b>Demographic Indicators: </b>Not Applicable  

<b>SORN: </b> https://www.federalregister.gov/documents/2022/01/24/2022-01066/privacy-act-of-1974-system-of-records 

<b>Data Use Agreement: </b>Unavailable 

<b>Data Use Agreement Location: </b> Not Applicable 

<b>Granularity: </b>State 

<b>Spatial: </b>United States 

<b>Geocoding: </b>Unavailable
Miami

Data tables consisting of Excel files with estimates, rates, relative standard errors, trends and confidence intervals, covering 2004-2011, for drug-related emergency department visits for the Miami-Dade Division of the Miami Metropolitan Statistical Area. Tables are provided for 10 topics (\"analytic categories\") which are defined in the \"Guide to Drug Abuse Warning Trend Tables,\" a separate document.   Each table includes data for over 500 drugs, including illicit drugs, prescription and over-the-counter medications, dietary supplements, inhalants and alcohol. Includes total visits, gender, age group, race/ethnicity, outcome of visit, drug combinations, number of drugs involved in visit, drug frequency, and drugs confirmed by toxicology. Additional detail is provided for illicit drugs, psychotherapeutic drugs, central nervous system (CNS) drugs, respiratory drugs and cardiovascular drugs.
Mental Health Care in the Last 4 Weeks

The U.S. Census Bureau, in collaboration with five federal agencies, launched the Household Pulse Survey to produce data on the social and economic impacts of Covid-19 on American households.  The Household Pulse Survey was designed to gauge the impact of the pandemic on employment status, consumer spending, food security, housing, education disruptions, and dimensions of physical and mental wellness.

The survey was designed to meet the goal of accurate and timely weekly estimates. It was conducted by an internet questionnaire, with invitations to participate sent by email and text message. The sample frame is the Census Bureau Master Address File Data. Housing units linked to one or more email addresses or cell phone numbers were randomly selected to participate, and one respondent from each housing unit was selected to respond for him or herself. Estimates are weighted to adjust for nonresponse and to match Census Bureau estimates of the population by age, gender, race and ethnicity, and educational attainment. All estimates shown meet the NCHS Data Presentation Standards for Proportions.
Dallas-Fort Worth-Arlington, TX

This report presents combined 2005 to 2010 National Survey on Drug Use and Health (NSDUH) results for those aged 12 or older in the Dallas-Fort Worth-Arlington, TX metro area. The report includes estimates of substance use disorder, major depressive episode, illicit drug use, marijuana use, cigarette use, binge alcohol use, and the nonmedical use of prescription-type pain relievers. Results are provided for the Dallas-Fort Worth-Arlington metro area, Texas, and the U.S. overall.
Comparison Between 2021-2022 NSDUH State Prevalence Estimates

Compare state and regional estimates for 35 measures of substance use and mental health using p-values. The tables are a companion to thestate-level estimatesfrom the 2021-2022 National Surveys on Drug Use and Health (NSDUH). This collection consists of several sets of p-value tables, along with a guide for their use in determining if differences between two geographic areas are statistically significant.